One study showed that high-dose vitamin D3 supplementation of 40,000 IU/week (~5700 IU/d) for 24 weeks was associated with improvement in clinical manifestation, cutaneous microcirculation and inflammatory markers (decreased IL-6 and increased IL-10) in patients with T2DM and peripheral neuropathy [50]. Here, IL10 is linked to peripheral neuropathy.